AY

Abhijeet Yogeshkumar Itai

Active Director Director DIN 09471196
DIN 09471196 First appointment Jan 2022 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Abhijeet Yogeshkumar Itai

Data last updated:

Abhijeet Yogeshkumar Itai is a Director at Radvision Healthcare Private Limited (since 2022). The company operates in Healthcare.

DIN 09471196
Primary Designation Director
Industry Healthcare
First Appointment 18 Jan 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Radvision Healthcare Private Limited U24299PN2022PTC207754
Director18 Jan 20222022Active

Board colleagues of Abhijeet Yogeshkumar Itai

Directorship timeline

Open interactive timeline →
Radvision Healthcare Private Limited
Premium access

Shareholding and investment profile for Abhijeet Yogeshkumar Itai

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abhijeet Yogeshkumar Itai

Abhijeet Yogeshkumar Itai currently holds 1 directorship: Radvision Healthcare Private Limited (Director, since 18 Jan 2022).

Abhijeet Yogeshkumar Itai was first appointed on 18 Jan 2022 as Director at Radvision Healthcare Private Limited.

The current boards of Abhijeet Yogeshkumar Itai's companies include Hrishikesh Suresh Chavan (Radvision Healthcare Private Limited), Vikram Tukaram Shewale (Radvision Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available